142 related articles for article (PubMed ID: 27491535)
1. The use of thermographic imaging to evaluate therapeutic response in human tumour xenograft models.
Hussain N; Connah D; Ugail H; Cooper PA; Falconer RA; Patterson LH; Shnyder SD
Sci Rep; 2016 Aug; 6():31136. PubMed ID: 27491535
[TBL] [Abstract][Full Text] [Related]
2. Thermographic assessment of tumor growth in mouse xenografts.
Song C; Appleyard V; Murray K; Frank T; Sibbett W; Cuschieri A; Thompson A
Int J Cancer; 2007 Sep; 121(5):1055-8. PubMed ID: 17487841
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy of thermographic breast imaging in breast cancer: A pilot study.
Prasad SS; Ramachandra L; Kumar V; Dave A; Mestha LK; Venkatarmani K
Breast Dis; 2016; 36(4):143-147. PubMed ID: 27767959
[TBL] [Abstract][Full Text] [Related]
4. Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenografts.
Delgado San Martin JA; Hare JI; Yates JW; Barry ST
Nanomedicine; 2015 Jul; 11(5):1247-52. PubMed ID: 25752857
[TBL] [Abstract][Full Text] [Related]
5. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.
Rodrigues HF; Mello FM; Branquinho LC; Zufelato N; Silveira-Lacerda EP; Bakuzis AF
Int J Hyperthermia; 2013 Dec; 29(8):752-67. PubMed ID: 24138472
[TBL] [Abstract][Full Text] [Related]
6. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R
BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.
Atkinson JM; Falconer RA; Edwards DR; Pennington CJ; Siller CS; Shnyder SD; Bibby MC; Patterson LH; Loadman PM; Gill JH
Cancer Res; 2010 Sep; 70(17):6902-12. PubMed ID: 20663911
[TBL] [Abstract][Full Text] [Related]
8. The chorioallantoic membrane as a bio-barrier model for the evaluation of nanoscale drug delivery systems for tumour therapy.
Preis E; Schulze J; Gutberlet B; Pinnapireddy SR; Jedelská J; Bakowsky U
Adv Drug Deliv Rev; 2021 Jul; 174():317-336. PubMed ID: 33905805
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model.
Su CC; Yang JS; Lu CC; Chiang JH; Wu CL; Lin JJ; Lai KC; Hsia TC; Lu HF; Fan MJ; Chung JG
Phytother Res; 2010 Feb; 24(2):189-92. PubMed ID: 20077433
[TBL] [Abstract][Full Text] [Related]
10. Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.
Jiang Y; Allen D; Kersemans V; Devery AM; Bokobza SM; Smart S; Ryan AJ
Lung Cancer; 2015 Nov; 90(2):191-8. PubMed ID: 26323213
[TBL] [Abstract][Full Text] [Related]
11. Specific thermographic changes during Walker 256 carcinoma development: differential infrared imaging of tumour, inflammation and haematoma.
Poljak-Blazi M; Kolaric D; Jaganjac M; Zarkovic K; Skala K; Zarkovic N
Cancer Detect Prev; 2009; 32(5-6):431-6. PubMed ID: 19232842
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model.
Christowitz C; Davis T; Isaacs A; van Niekerk G; Hattingh S; Engelbrecht AM
BMC Cancer; 2019 Aug; 19(1):757. PubMed ID: 31370818
[TBL] [Abstract][Full Text] [Related]
13. Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist.
Pitman KE; Bakke KM; Kristian A; Malinen E
Cancer Imaging; 2019 Dec; 19(1):88. PubMed ID: 31856923
[TBL] [Abstract][Full Text] [Related]
14. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review.
Jin K; Teng L; Shen Y; He K; Xu Z; Li G
Clin Transl Oncol; 2010 Jul; 12(7):473-80. PubMed ID: 20615824
[TBL] [Abstract][Full Text] [Related]
16. Reliability and repeatability of thermographic examination and the normal thermographic image of the thoracolumbar region in the horse.
Tunley BV; Henson FM
Equine Vet J; 2004 May; 36(4):306-12. PubMed ID: 15163036
[TBL] [Abstract][Full Text] [Related]
17. A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM
Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842
[TBL] [Abstract][Full Text] [Related]
18. Continuous thermographic observation may predict extravasation in chemotherapy-treated patients.
Oya M; Murayama R; Oe M; Yabunaka K; Tanabe H; Takahashi T; Matsui Y; Otomo E; Komiyama C; Sanada H
Eur J Oncol Nurs; 2017 Jun; 28():56-61. PubMed ID: 28478856
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts.
Cornillie J; Wozniak A; Van Renterghem B; Van Winkel N; Wellens J; Gebreyohannes YK; Debiec-Rychter M; Sciot R; Hompes D; Schöffski P
BMC Cancer; 2019 Jul; 19(1):724. PubMed ID: 31331295
[TBL] [Abstract][Full Text] [Related]
20. Murine xenograft model demonstrates significant radio-sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma.
Petznek H; Kleiter M; Tichy A; Fuchs-Baumgartinger A; Hohenadl C
Res Vet Sci; 2014 Oct; 97(2):386-90. PubMed ID: 25104320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
